Cover Image
Market Research Report

Organ-on-a-Chip: Global Markets

Published by BCC Research Product code 895033
Published Content info 134 Pages
Delivery time: 1-2 business days
Price
Back to Top
Organ-on-a-Chip: Global Markets
Published: July 23, 2019 Content info: 134 Pages
Description

Report Highlights:

The global market for organ-on-a-chip should grow from $11.3 billion in 2018 to $60.6 billion by 2023 at a compound annual growth rate (CAGR) of 39.9% from 2018 to 2023.

Heart as a segment of organ-on-a-chip market should grow from $2.6 billion in 2018 to $14.4 billion by 2023 at a CAGR of 41.2% from 2018 to 2023.

Liver as a segment of organ-on-a-chip market should grow from $2.4 billion in 2018 to $13.4 billion by 2023 at a CAGR of 40.9% from 2018 to 2023.

Report Scope:

The scope of this report is broad and covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down by product into instruments and consumables. Revenue forecasts from 2018 to 2023 are given for each product, application, cell type and end user, with estimated valued derived from the revenues of manufacturers. Revenue generated from the installation and maintenance of instruments has been excluded from the report.

This report also includes a discussion of the major players in each regional organ-on-a-chip market. Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major players in the global organ-on-a-chip market.

Report Includes:

  • 56 data tables and 49 additional tables
  • An overview of global market for organ-on-a-chip within the industry
  • Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Description of potential applications in pharmaceutical and life science research sectors, including preclinical drugs testing, drug screening, personalized medicine, phenotypic screening, lead optimization and disease modelling
  • Information on multi-channel 3-D microfluidic cell culture chip and discussion of their ability to imitate human micro environment in vitro
  • Discussion on how organ on a chip is emerging as a priority testing alternative which is replacing animals in life science research, toxicology testing and drug development studies
  • Knowledge about implementation of 3rs (replacement, refinement and reduction of animals-based research) in the industry
  • Insights into government programs and policies in support of organ on chip and coverage of revised laws involving animal testing
  • Company profiles of the top players in the industry, including Emulate, Hurel Corp., Insphero, Organovo and Synvivo
Table of Contents
Product Code: BIO188A

Table of Contents

Chapter 1 - Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 - Summary and Highlights

Chapter 3 - Market and Technology Background

  • Introduction
  • Developments in Drug Discovery
    • 1950-1970
    • 1970-1990
    • 1990-2010
    • 2010 to the Present
  • Market Potential
  • Investment Analysis
  • Regulatory Framework
    • United States
    • European Union
    • China
    • Japan
  • Industry Growth Drivers
    • Rising Demand to Enhance the Effectiveness of Clinical Trials
    • Increasing Investments for Drug Research and Development
    • Increasing Adoption of Organ-on-a-Chip in Multiple Applications
    • Surging Demand of Lung-Based Organ Cultures in Clinical Studies

Chapter 4 - Global Organ-on-a-Chip Market by Type

  • Liver
    • Liver on a Chip Classification Depending on Their Principal Actions
  • Heart
  • Kidney
  • Lung
  • Other Organs

Chapter 5 - Global Organ-on-a-Chip Market by End User

  • Biotechnology and Pharmaceutical Companies
  • Cosmetics Industry
  • Academic and Research Institutes
    • Increasing R&D Spending
  • Other End Users

Chapter 6 - Global Organ-on-a-Chip Market by Offering

  • Products
  • Services

Chapter 7 - Global Organ-on-a-Chip Market by Application

  • Drug Discovery and Development
  • Toxicological Research
  • Physiological Model Development

Chapter 8 - Global Organ-on-a-Chip Market by Region

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Chapter 9 - Organ-on-a-Chip Industry Structure

  • Raw Material Suppliers
    • Quality and Technology
    • Terms and Conditions
    • Cost-Effective Components
  • Manufacturers
  • Distributors
  • End Users of Consumables
  • Innovation Within the Industry
  • Competitive Analysis

Chapter 10 - Company Profiles

  • 4DCELL
  • AXOSIM
  • BEONCHIP
  • BIOMIMX
  • BIOIVT
  • CHERRY BIOTECH
  • CN BIO
  • ELVEFLOW
  • EMULATE, INC.
  • FLUIGENT
  • HESPEROS, INC.
  • HUREL CORP.
  • INSPHERO
  • KIRKSTALL
  • MICRONIT
  • MESOBIO TECH
  • MIMETAS
  • NORTIS
  • ORGANOVO
  • SYNVIVO
  • TARA BIOSYSTEMS, INC.
  • TISSUSE GMBH

List of Tables

  • Summary Table: Global Organ-on-a-Chip Market, by Type, Through 2023
    • Table 1: Drug Development Time Span
    • Table 2: Advantages of Organ-on-a-Chip Compared to Traditional Methods of Drug Discovery
    • Table 3: U.S. NIH Funding for Various Disease Conditions, 2014-2019
    • Table 4: Number of Animals Used for Clinical Research, by Country, 2016-2017
    • Table 5: Global Organ-on-a-Chip Market, by Type, Through 2023
    • Table 6: Liver-on-a-Chip Classifications
    • Table 7: Global Liver Organ-on-a-Chip Market, by Region, Through 2023
    • Table 8: Global Heart Organ-on-a-Chip Market, by Region, Through 2023
    • Table 9: Deaths from CVD and Number of People Living with CVD in United Kingdom, 2016
    • Table 10: Global Kidney Organ-on-a-Chip Market, by Region, Through 2023
    • Table 11: Global Burden of Chronic Kidney Disease, 1990 and 2016
    • Table 12: Global Lung Organ-on-a-Chip Market, by Region, Through 2023
    • Table 13: Mortality Rates Due to Leading Respiratory Causes, 2008-2030
    • Table 14: Global Other Organ-on-a-Chip Market, by Region, Through 2023
    • Table 15: Global Organ-on-a-Chip Market, by End User, Through 2023
    • Table 16: Global Biotechnology and Pharmaceutical Company Revenues from the Organ-on- a-Chip Market, by Region, Through 2023
    • Table 17: U.S. Pharmaceutical R&D Spending, 2005-2015
    • Table 18: R&D Spending, by India's Six Largest Pharma Companies, 2016
    • Table 19: Global Cosmetics Industry Revenues from the Organ-on-a-Chip Market, by Region, Through 2023
    • Table 20: Global Academic and Research Institution Revenues from the Organ-on-a-Chip Market, by Region, Through 2023
    • Table 21: Current Grants, by Cancer Type, 2018
    • Table 22: Global Prevalence of Dementia, 2015-2050
    • Table 23: Global Other End Users of Organ-on-a-Chip Market, by Region, Through 2023
    • Table 24: Global Organ-on-a-Chip Market, by Offering, Through 2023
    • Table 25: Global Organ-on-a-Chip Products Market, by Region, Through 2023
    • Table 26: Global Organ-on-a-Chip Services Market, by Region, Through 2023
    • Table 27: Global Organ-on-a-Chip Market, by Application, Through 2023
    • Table 28: Global Pharmaceutical Market, 2015 and 2020
    • Table 29: Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2016
    • Table 30: Global Organ-on-a-Chip Market in Drug Discovery and Development, by Region, Through 2023
    • Table 31: Global Pharmaceutical R&D Spending, by Year, 2015-2022
    • Table 32: Member Companies of the Pharmaceutical Research and Manufacturers' R&D Investment in the U.S., 2010-2016
    • Table 33: Global Organ-on-a-Chip Market in Toxicological Research, by Region, Through 2023
    • Table 34: Global Organ-on-a-Chip Market in Physiological Model Development, by Region, Through 2023
    • Table 35: Global Prevalence of Cancer, by Type, 2016
    • Table 36: Global Organ-on-a-Chip Market, by Region, Through 2023
    • Table 37: North American Organ-on-a-Chip Market, by Product, Through 2023
    • Table 38: North American Organ-on-a-Chip Market, by Application, Through 2023
    • Table 39: North American Organ-on-a-Chip Market, by End User, Through 2023
    • Table 40: North American Organ-on-a-Chip Market, by Offering, Through 2023
    • Table 41: NIH Spending on Stem Cell Research in the U.S., by Year, 2013-2016
    • Table 42: Shares of the Annual Budget of the Canadian Institutes of Health Research, by Type of Research, 2016
    • Table 43: European Organ-on-a-Chip Market, by Type, Through 2023
    • Table 44: European Organ-on-a-Chip Market, by End User, Through 2023
    • Table 45: European Organ-on-a-Chip Market, by Offering, Through 2023
    • Table 46: European Organ-on-a-Chip Market, by Application, Through 2023
    • Table 47: Government Funding for Drug-Related Research in France, 2010-2016
    • Table 48: Rising Prevalence of Cancer Cases in Spain, 2012 and 2015
    • Table 49: Percentage of Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
    • Table 50: Rising Prevalence of Breast Cancer Cases in Norway, 2014-2015
    • Table 51: Asia-Pacific Organ-on-a-Chip Market, by Type, Through 2023
    • Table 52: Asia-Pacific Organ-on-a-Chip Market, by Offering, Through 2023
    • Table 53: Asia-Pacific Organ-on-a-Chip Market, by End User, Through 2023
    • Table 54: Asia-Pacific Organ-on-a-Chip Market, by Application, Through 2023
    • Table 55: Growth in Japanese Pharmaceutical Industry, 2010-2015
    • Table 56: R&D Spending, by Top Six Pharmaceutical Companies in India, 2018
    • Table 57: Overall R&D Expenditures in Rest of the World, 2017
    • Table 58: Rest of the World Organ-on-a-Chip Market, by Application, Through 2023
    • Table 59: Rest of the World Organ-on-a-Chip Market, by Offering, Through 2023
    • Table 60: Rest of the World Organ-on-a-Chip Market, by End User, Through 2023
    • Table 61: Rest of the World Organ-on-a-Chip Market, by Type, Through 2023
    • Table 62: Capital Raised by Israeli High-Tech Companies, 2013-2017
    • Table 63: Raw Material/Part Manufacturers
    • Table 64: Manufacturers Operating in the Organ-on-a-Chip Market
    • Table 65: End Users of Consumables Operating in the Organ-on-a-Chip Market
    • Table 66: Shares of Competitive Strategies Used in the Global Organ-on-a-chip Market, 2015-2018
    • Table 67: 4Dcell: Product Portfolio
    • Table 68: AxoSim, Inc.: Product Portfolio
    • Table 69: AxoSim, Inc.: Recent Developments, 2016-2019
    • Table 70: BEOnChip: Product Portfolio
    • Table 71: BEOnChip: Recent Developments, 2016-2018
    • Table 72: BiomimX: Product Portfolio
    • Table 73: BioIVT: Product Portfolio
    • Table 74: BioIVT: Recent Developments, 2016-2018
    • Table 75: Cherry Biotech: Product Portfolio
    • Table 76: CN Bio: Product Portfolio
    • Table 77: CN Bio: Recent Developments, 2016-2018
    • Table 78: Elveflow: Product Portfolio
    • Table 79: Elveflow: Recent Developments, 2016-2018
    • Table 80: Emulate, Inc.: Product Portfolio
    • Table 81: Emulate, Inc.: Recent Developments, 2016-2018
    • Table 82: Fluigent: Product Portfolio
    • Table 83: Fluigent: Recent Developments, 2016-2018
    • Table 84: Hesperos, Inc.: Product Portfolio
    • Table 85: Hesperos, Inc.: Recent Developments, 2016-2018
    • Table 86: Hurel Corp.: Product Portfolio
    • Table 87: Hurel Corp.: Recent Developments, 2016-2018
    • Table 88: InSphero: Product Portfolio
    • Table 89: InSphero: Recent Developments, 2016-2018
    • Table 90: Kirkstall Ltd.: Product Portfolio
    • Table 91: Micronit: Product Portfolio
    • Table 92: Micronit: Recent Developments, 2016-2018
    • Table 93: MesoBio Tech: Product Portfolio
    • Table 94: Mimetas B.V.: Product Portfolio
    • Table 95: Mimetas B.V.: Recent Developments, 2016-2019
    • Table 96: Nortis: Product Portfolio
    • Table 97: Organovo: Product Portfolio
    • Table 98: Organovo: Recent Developments, 2016-2018
    • Table 99: SynVivo: Product Portfolio
    • Table 100: SynVivo: Recent Developments, 2016-2018
    • Table 101: Tara Biosystems, Inc.: Product Portfolio
    • Table 102: Tara Biosystems, Inc.: Recent Developments, 2016-2019
    • Table 103: Tissuse GmbH: Product Portfolio
    • Table 104: Tissuse GmbH: Recent Developments, 2016-2018

List of Figures

  • Summary Figure: Global Organ-on-a-Chip Market, by Type, 2017-2023
    • Figure 1: Development of Organ-on-a-Chip
    • Figure 2: Drug Research Cycle
    • Figure 3: FDA Stages of New Medicine Review and Regulation
    • Figure 4: Research and Development Process of a Drug
    • Figure 5: Comparison of the Pipelines of Priority R&D Projects of the Top 20 Companies, by Disease Type, 2018
    • Figure 6: Global Pharmaceutical R&D Spending, 2015-2022
    • Figure 7: U.S. NSF Funding for Biological Science Research Studies, 2017
    • Figure 8: Global Tissue Engineering and Cell Therapy Market Growth, 2009-2018
    • Figure 9: Major Applications of Organ-on-a-Chip
    • Figure 10: Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
    • Figure 11: Share of Heart Disease Deaths in the U.S., by Disease, 2017
    • Figure 12: Organ-on-a-Chip Market End Users
    • Figure 13: Major Factors Driving the Growth of the Organ-on-a-Chip Market
    • Figure 14: U.S. Pharmaceutical R&D Spending, 2005-2015
    • Figure 15: R&D Spending, by India's Six Largest Pharma Companies, 2016
    • Figure 16: Shares of Global R&D Funding, by Region, 2018
    • Figure 17: Top 10 Countries' R&D Expenditures in Drug Discovery and the Life Sciences, 2016-2018
    • Figure 18: Global Prevalence of Dementia, 2015-2050
    • Figure 19: Key Products: Organ-on-a-Chip
    • Figure 20: Global Pharmaceutical Market, 2015 and 2020
    • Figure 21: Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2016
    • Figure 22: Global Pharmaceutical R&D Spending, by Year, 2015-2022
    • Figure 23: Member Companies of Pharmaceutical Research and Manufacturers' R&D Investment in the U.S., 2010 and 2016
    • Figure 24: Global Prevalence of Cancer, by Type, 2016
    • Figure 25: NIH Spending on Stem Cell Research in the U.S., by Year, 2013-2016
    • Figure 26: Shares of the Annual Budget of the Canadian Institute of Health Research, by Type of Research, 2016
    • Figure 27: Government Funding for Drug-Related Research in France, 2010-2016
    • Figure 28: Rising Prevalence of Cancer Cases in Spain, 2012 and 2015
    • Figure 29: Growth in Japanese Pharmaceutical Industry, 2010-2015
    • Figure 30: R&D Spending, by the Top Six Pharmaceutical Companies in India, 2018
    • Figure 31: Overall R&D Expenditures in Rest of the World, 2016-2017
    • Figure 32: Capital Raised by Israeli High-Tech Companies, 2013-2017
    • Figure 33: Industry Structure of Instruments Used in the Organ-on-a-Chip Market
    • Figure 34: Shares of Competitive Strategies Used in the Global Organ-on-a-chip Market, 2015-2018
Back to Top